Published in J Exp Med on October 01, 2001
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med (2009) 2.77
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst (2012) 2.09
Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol (2008) 1.79
Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol (2010) 1.74
IL-33 promotes DC development in BM culture by triggering GM-CSF production. Eur J Immunol (2009) 1.74
Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A (2009) 1.49
Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 1.46
Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J Exp Med (2003) 1.39
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ (2007) 1.35
Dendritic cells and immunity against cancer. J Intern Med (2011) 1.32
Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J Virol (2006) 1.20
The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood (2012) 1.15
Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 1.09
Regulating the immune system via IL-15 transpresentation. Cytokine (2012) 1.08
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. J Transl Med (2009) 1.05
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential. PLoS One (2012) 1.04
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1. Blood (2012) 1.02
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol (2013) 1.02
Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infect Immun (2004) 1.01
Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res (2010) 1.01
Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol (2004) 1.00
Dendritic cells: a critical player in cancer therapy? J Immunother (2008) 0.99
Antiviral-activated dendritic cells: a paracrine-induced response state. J Immunol (2008) 0.97
CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin Exp Immunol (2009) 0.94
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine (2008) 0.94
Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res (2011) 0.93
Building on dendritic cell subsets to improve cancer vaccines. Curr Opin Immunol (2010) 0.93
Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection. J Theor Biol (2009) 0.93
Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. Clin Cancer Res (2011) 0.92
Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation. J Transl Med (2010) 0.92
Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS One (2008) 0.91
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection. J Clin Invest (2013) 0.91
Dendritic cells: are they clinically relevant? Cancer J (2010) 0.90
15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level. J Transl Med (2011) 0.87
Brucella discriminates between mouse dendritic cell subsets upon in vitro infection. Virulence (2015) 0.87
On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response. J Immunol (2002) 0.86
Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy. Biomaterials (2009) 0.86
Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) (2012) 0.85
Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators Inflamm (2012) 0.85
GM-CSF-independent CD1a expression in epidermal Langerhans cells: evidence from human CD1A genome-transgenic mice. J Invest Dermatol (2011) 0.84
Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. Blood (2012) 0.83
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner. PLoS One (2015) 0.83
Cellular immunotherapy for ovarian cancer. Expert Opin Biol Ther (2009) 0.83
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy. Hum Vaccin Immunother (2013) 0.82
HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc Disord (2003) 0.82
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation. Immunology (2010) 0.81
Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response. Arthritis Res (2002) 0.81
Transcriptional IL-15-directed in vivo DC targeting DNA vaccine. Gene Ther (2009) 0.81
Dendritic cell subsets as vectors and targets for improved cancer therapy. Curr Top Microbiol Immunol (2011) 0.79
Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy. Clin Dev Immunol (2013) 0.79
Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review. J Immune Based Ther Vaccines (2004) 0.78
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy. Vaccines (Basel) (2013) 0.78
Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells. J Immune Based Ther Vaccines (2010) 0.78
STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells. Immunol Cell Biol (2015) 0.77
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells. J Cell Mol Med (2014) 0.77
Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen. Clin Exp Immunol (2005) 0.77
Different maturation cocktails provide dendritic cells with different chemoattractive properties. J Transl Med (2015) 0.77
Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients. World J Gastroenterol (2015) 0.77
Advances in cellular therapy for the treatment of thyroid cancer. J Oncol (2010) 0.76
Heterogeneity, functional specialization and differentiation of monocyte-derived dendritic cells. Immunol Cell Biol (2016) 0.76
Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes. PLoS One (2015) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med (2000) 9.78
Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02
IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity (1998) 8.29
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 6.22
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol (1999) 3.81
A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med (1996) 2.72
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68
A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity (1998) 2.56
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol (1996) 1.87
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62
A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol (1999) 1.57
Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest (1998) 1.50
Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol (1999) 1.39
Interleukin (IL)-15 promotes the growth of murine epidermal gamma delta T cells by a mechanism involving the beta- and gamma c-chains of the IL-2 receptor. J Invest Dermatol (1995) 0.98
Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol (1995) 0.90
Interleukin-15 expression by human endothelial cells: up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol Photoimmunol Photomed (1996) 0.84
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science (2001) 8.14
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
CD40-CD40 ligand. J Leukoc Biol (2000) 6.28
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med (1997) 5.23
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 5.06
IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A (1988) 5.03
Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci U S A (1986) 4.59
Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med (1994) 4.52
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci U S A (1987) 3.98
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82
IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol (1988) 3.47
Generation of memory B cells and plasma cells in vitro. Science (1995) 3.45
Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med (1992) 3.40
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol (2000) 3.39
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res (2001) 3.01
Immunodeficiency in protein kinase cbeta-deficient mice. Science (1996) 2.79
Sensing pathogens and tuning immune responses. Science (2001) 2.73
Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol (1989) 2.71
Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64
Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol (1997) 2.62
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol (1990) 2.58
Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity (1995) 2.57
A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity (1998) 2.56
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med (1999) 2.54
Ligation-anchored PCR: a simple amplification technique with single-sided specificity. Proc Natl Acad Sci U S A (1992) 2.50
Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med (1994) 2.50
Recycling of transferrin receptors in A431 cells is inhibited during mitosis. EMBO J (1984) 2.42
Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med (1998) 2.39
Interleukin-17. Int Rev Immunol (1998) 2.31
Fringe pattern photobleaching, a new method for the measurement of transport coefficients of biological macromolecules. EMBO J (1982) 2.30
The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol (1998) 2.27
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23
Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity (1996) 2.22
Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med (1997) 2.21
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Dendritic cells as vectors for therapy. Cell (2001) 2.18
IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol (1988) 2.16
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med (1994) 2.14
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J Exp Med (1997) 2.14
Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13
Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol (2001) 2.10
Cytokinesis arrest and redistribution of actin-cytoskeleton regulatory components in cells expressing the Rho GTPase CDC42Hs. J Cell Sci (1996) 2.08
Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med (1993) 2.00
Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE. J Immunol (1987) 1.99
Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol (1997) 1.97
Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med (1993) 1.96
The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol (1999) 1.93
Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol (2000) 1.93
Dendritic cells capable of stimulating T cells in germinal centres. Nature (1996) 1.90
Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol Rev (1988) 1.84
Differentiation state-dependent surface mobilities of two forms of the neural cell adhesion molecule. Nature (1987) 1.78
Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood (1990) 1.75
Programmed cell death in Dictyostelium. J Cell Sci (1994) 1.73
CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol (1996) 1.70
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med (1997) 1.69
Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol (1995) 1.69
Microtubules are stabilized in confluent epithelial cells but not in fibroblasts. J Cell Biol (1990) 1.69
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol (1988) 1.67
Modulating the immune response with dendritic cells and their growth factors. Trends Immunol (2001) 1.66
Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol (1995) 1.63
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62
Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med (2002) 1.61
Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol (1998) 1.60
Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature (1992) 1.60
Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med (1997) 1.59
Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med (2000) 1.59
Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J Immunol (2000) 1.58
B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood (1996) 1.57
Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. Immunity (1996) 1.56
Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med (1996) 1.55
Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J (1996) 1.53
Dendritic cells: On the move from bench to bedside. Nat Med (2001) 1.52
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood (1993) 1.52
Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol (1998) 1.52
Dendritic cells. Adv Immunol (1999) 1.51
Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum (1990) 1.51
Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol (2001) 1.49
Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol (1998) 1.47
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol (1997) 1.46